Zhong Ding Kai Rui Tech Co. ,LTD was established on August 20, 2018 with a registered capital of 30 million yuan. The company is located in the Chengdu Economic and Technological Development Zone, the land of abundance. It is a professional company dedicated to the research and development of bone repair materials, biomedical materials and their products. A high-tech enterprise integrating production, sales and service. Zhongding Kerry has always adhered to the tenet of "Science, High Efficiency, Accuracy and Reliability", "Market Demand-Oriented", and "Industry-University-Research to create a healthy future together", committed to providing a brand new solution for the treatment of patients with bone defects Program.
The company has a high-quality R&D team, led by the doctoral supervisor of Sichuan University, and has established a long-term stable cooperative relationship with well-known domestic university hospitals. It has been committed to the research and development of biomedical materials for a long time, and many research results have entered the conversion of results. stage.
The three types of implants degradable composite bone grafts developed by our company belong to the national key support and encouragement industries and have independent independent intellectual property rights. The composite bone grafts form a self-solidifying and can be used for Minimally invasive surgery can solve clinical bone defects caused by trauma, deformity, bone tumor, osteomyelitis, etc. through in-situ composite or pre-molding. It is a class of composite bone repair materials with excellent performance.
In an increasingly competitive international market environment, only scientific methods can be used to act quickly to develop accurate and reliable research and development results of biomaterials to meet the product needs of the clinical market, achieve independent innovation, import substitution, and reduce the burden on patients. The strength of human medical and health struggle. At present, our company is advancing along the life science road of "independence, innovation," with the pace of "scientific and efficient".
